Another interesting hypothesis, linked to the reduction in glomerular hyperfiltration, is that SGLT2 inhibitors correct the intrarenal mismatch between oxygen delivery and oxygen demand characteristic of diabetes and thereby improve kidney oxygenation [4]. Here, SLC5A2 is linked to diabetes mellitus.